Cana­da wants to clear the way for more de­cen­tral­ized clin­i­cal tri­als: Will the US fol­low suit?

The clin­i­cal tri­al ecosys­tem in North Amer­i­ca was up­end­ed quick­ly by Covid-19, cast­ing a gi­ant spot­light on in­ef­fi­cien­cies and the need to make room for more de­cen­tral­ized clin­i­cal tri­als.

And Cana­da is pre­pared to do just that, re­veal­ing in a sum­ma­ry on Wednes­day in its pro­pos­al to mod­ern­ize its clin­i­cal tri­al sys­tem that en­abling more of these de­cen­tral­ized tri­als — cen­tered on pa­tients rather than a sin­gle or mul­ti­ple tri­al sites — “is an im­por­tant ini­tia­tive, as over 30% of the pop­u­la­tion lives out­side medi­um-sized and large ur­ban ar­eas.”

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER